Rate Reality Check: How Capital Women’s Care Stacks Up Against the Competition (Part 2)
By JASON HINES This is Part 2 of Jason and Gigasheets’ investigation into the Capital Women’s…
Rate Reality Check: How Capital Women’s Care Stacks Up Against the Competition (Part 2)
By JASON HINES This is Part 2 of Jason and Gigasheets’ investigation into the Capital Women’s Care vs UnitedHealthcare contract dispute in which (partially at my request) he expanded the investigation to look at other providers in the same market. Revealing stuff!–Matthew Holt While Capital Women’s Care (CWC) battles UnitedHealthcare over contract terms, a deeper look at…
CMMI’s New Strategic Direction
The Center for Medicare and Medicaid Innovation (CMMI) recently released a new strategy to “Make America Healthy Again.” The strategy includes: Promoting evidence-based preventionEmpowering people to achieve their health goalsDriving choice and competition for people A Health Affairs Forefront article from Joshua M. Liao notes three broad goals: increasing patient engagement, better leveraging data and…
Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short
The One Big Beautiful Bill Act introduced a new $50 billion fund to offer rural hospitals a financial lifeline. One expert cautions that this effort will fail to address systemic challenges without transparency, clear metrics and long-term infrastructure investment strategies. The post Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short appeared first…
Report: Member Satisfaction in MA Insurers Is Dropping Due to Lack of Trust
Overall customer satisfaction in Medicare Advantage plans is 623 points on a 1,000-point scale, a 29-point drop from last year, according to a new report from J.D. Power. The post Report: Member Satisfaction in MA Insurers Is Dropping Due to Lack of Trust appeared first on MedCity News.
Income and Assets of Medicare Beneficiaries in 2024
This brief examines the income, assets, and home equity of Medicare beneficiaries, overall and by age, race and ethnicity, and gender, using data derived from the Dynamic Simulation of Income Model (DYNASIM) for 2024. The analysis highlights that most Medicare beneficiaries live on relatively low incomes and have modest financial resources to draw upon in…
Estos son los aumentos de precios que también deberían preocuparte
Preocupados por la inflación, los estadounidenses han estado atentos a precios de productos cotidianos como los huevos y la gasolina. Pero un gasto menos conocido debería causar más alarma: el aumento de las primas de los seguros médicos. Llevan años subiendo, y ahora lo están haciendo a un ritmo sin precedentes. Hay que considerar que,…
FDA Suspends Valneva Vaccine’s License Following New Reports of Adverse Events
Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a pause on dosing of Ixchiq, but the agency’s new safety alert is based on an assessment that found the vaccine appears to be causing chikungunya-like illness in recipients. The post FDA Suspends Valneva Vaccine’s License…
The Top-Rated Assistive Devices for Children With Sensory Processing Disorders
[Sponsored] The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. The post The Top-Rated Assistive Devices for Children With Sensory Processing Disorders appeared first on MedCity News.
Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment
If we truly believe in treating the whole patient, we must recognize that survival is not the only measure of success. Preserving a woman’s sense of self, her dignity, her identity, her autonomy is just as essential. The post Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment appeared first…
Tariffs Are Driving up Premiums for Small Businesses
Some insurers in the ACA’s small group market are citing tariffs, particularly those affecting prescriptions drugs, as a reason for higher-than-expected premium increases.
